110221-44-8
中文名稱
鹽酸替莫普利
英文名稱
Temocapril hydrochloride
CAS
110221-44-8
分子式
C23H28N2O5S2.ClH
MDL 編號
MFCD00933433
分子量
513.076
MOL 文件
110221-44-8.mol
更新日期
2025/07/29 11:33:14
110221-44-8 結(jié)構(gòu)式
基本信息
中文別名
[(2S,6R)-6-[[(S)-1-(乙氧羰基)-3-苯基丙基]氨基]-5-氧代-2-(2-噻吩基)-1,4-硫氮雜卓-4-基]乙酸鹽酸鹽替莫普利鹽酸鹽
鹽酸替莫普利
英文別名
TEMOCAPRIL HYDROCHLORIDETemocapril Hcl
TemocarpileHCL
Temocarpilhydrochloride
(2S,6R)-6-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic Acid Hydrochloride
Acecol
CS-622
1,4-Thiazepine-4(5H)-acetic acid, 6-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]tetrahydro-5-oxo-2-(2-thienyl)-, monohydrochloride, (2S,6R)- (9CI)
1,4-Thiazepine-4(5H)-acetic acid, 6-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]tetrahydro-5-oxo-2-(2-thienyl)-, monohydrochloride, [2S-[2a,6b(R*)]]-
(+)-[(2S,6R)-6-[[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4-yl]acetic acid hydrochloride
(+)-[(2S,6R)-6-[[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-5-oxo-2-(2-thienyl)perhydro-1,4-thiazepin-4-yl]acetic acid hydrochloride
2-[(2S,6R)-6-[[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-5-oxo-2-(2-thienyl)-2,5,6,7-tetrahydro-1,4-thiazepine-4(3H)-yl]acetic acid·hydrochloride
所屬類別
生物化工：RAAS 抑制劑物理化學性質(zhì)
熔點196-2000C (dec)
比旋光度25D +47.7° (c = 1 in DMF)
儲存條件-20°C冷凍
溶解度DMF（微溶）、DMSO（微溶）、甲醇（微溶）
形態(tài)固體
顏色白色至灰白色
InChIKeyXDDQNOKKZKHBIX-VQDSPBDZNA-N
SMILES[C@@H]1(SC[C@H](N[C@H](C(=O)OCC)CCC2C=CC=CC=2)C(=O)N(CC(=O)O)C1)C1SC=CC=1.Cl |&1:0,3,5,r|
CAS 數(shù)據(jù)庫110221-44-8(CAS DataBase Reference)
安全數(shù)據(jù)
鹽酸替莫普利價格(試劑級)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/03/03 | S2099 | 鹽酸替莫普利 Temocapril HCl | 110221-44-8 | 10mg | 571.58元 |
| 2026/03/03 | S2099 | 鹽酸替莫普利 Temocapril HCl | 110221-44-8 | 25mg | 896.61元 |
| 2025/12/22 | HY-B0384 | 鹽酸替莫普利 Temocapril hydrochloride | 110221-44-8 | 5 mg | 304元 |
常見問題列表
生物活性
Temocapril HCl (CS-622)是Temocapril的鹽酸鹽形式，是一種長效的血管緊張素轉(zhuǎn)換酶（ACE）抑制劑，用于治療高血壓。靶點
| Target | Value |
| ACE |
體外研究
Temocapril hydrochloride is a prodrug of the ACE inhibitor, Temocaprilat. Temocapril hydrochloride can be readily uptaken via the human small intestine, and then be converted to its active metabolite (temocaprilat) by CES1 in the liver.
體內(nèi)研究
Temocapril hydrochloride (30 mg/kg; p.o.; daily; for 4 weeks) suppresses Angiotensin I-induced hypertension, plasma and renal ACE activity, but fails to reduce the level of Ang II in the kidney.
| Animal Model: | Male Sprague Dawley rats |
| Dosage: | 30 mg/kg |
| Administration: | Oral administration, daily, for 4 weeks |
| Result: | Suppressed the blood pressure elevation induced by Ang I. |